Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-10-16
2007-10-16
Chan, Christina (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S388150, C424S139100
Reexamination Certificate
active
10738120
ABSTRACT:
Isolated human monoclonal antibodies which bind to IL-8 (e.g., human IL-8) are disclosed. The human antibodies can be produced in a hybridoma, transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals, hybridomas, and transfectomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
REFERENCES:
patent: 5175384 (1992-12-01), Krimpenfort et al.
patent: 5204244 (1993-04-01), Fell et al.
patent: 5306627 (1994-04-01), Yamada et al.
patent: 5401643 (1995-03-01), Yamada et al.
patent: 5434340 (1995-07-01), Krimpenfort et al.
patent: 5440021 (1995-08-01), Chuntharapai et al.
patent: 5543503 (1996-08-01), Chuntharapai et al.
patent: 5552284 (1996-09-01), Lee et al.
patent: 5571702 (1996-11-01), Lee et al.
patent: 5633141 (1997-05-01), Lee et al.
patent: 5652338 (1997-07-01), Matsushima et al.
patent: 5677426 (1997-10-01), Fong et al.
patent: 5686070 (1997-11-01), Doerschuk et al.
patent: 5698196 (1997-12-01), Matsushima et al.
patent: 5702946 (1997-12-01), Doerschuk et al.
patent: 5707621 (1998-01-01), Matsushima
patent: 5707622 (1998-01-01), Fong et al.
patent: 5767063 (1998-06-01), Lee et al.
patent: 5769269 (1998-06-01), Peters
patent: 5776457 (1998-07-01), Lee et al.
patent: 5783415 (1998-07-01), Lee et al.
patent: 5831032 (1998-11-01), Schraufstatter et al.
patent: 5840856 (1998-11-01), Chuntharapai et al.
patent: 5856457 (1999-01-01), Lee et al.
patent: 5874080 (1999-02-01), Hebert et al.
patent: 5874543 (1999-02-01), Chuntharapai et al.
patent: 5892017 (1999-04-01), Lee et al.
patent: 5919896 (1999-07-01), Lee et al.
patent: 5922541 (1999-07-01), Lee et al.
patent: 5925352 (1999-07-01), Matsushima et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 6015557 (2000-01-01), Tobinick et al.
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6087475 (2000-07-01), Lee et al.
patent: 6114598 (2000-09-01), Kucherlapati et al.
patent: 6150584 (2000-11-01), Kucherlapati et al.
patent: 6162963 (2000-12-01), Kucherlapati et al.
patent: 6177077 (2001-01-01), Tobinick
patent: 6300129 (2001-10-01), Lonberg et al.
patent: 6376659 (2002-04-01), Matsushima et al.
patent: 6379660 (2002-04-01), Saavedra et al.
patent: 6419934 (2002-07-01), Tobinick
patent: 6419944 (2002-07-01), Tobinick
patent: 6423321 (2002-07-01), Tobinick
patent: 6428787 (2002-08-01), Tobinick
patent: 6436390 (2002-08-01), Tekamp-Olson et al.
patent: 6680209 (2004-01-01), Buechler et al.
patent: 6682736 (2004-01-01), Hanson et al.
patent: 2001/0006637 (2001-07-01), Akahoshi et al.
patent: 2002/0006405 (2002-01-01), Kitajima et al.
patent: 315062 (1994-01-01), None
patent: 955060 (1999-11-01), None
patent: 966971 (1999-12-01), None
patent: 991423 (2001-09-01), None
patent: WO 89/08665 (1989-09-01), None
patent: WO 89/10962 (1989-11-01), None
patent: WO 90/02178 (1990-03-01), None
patent: WO 90/04036 (1990-04-01), None
patent: WO 90/12878 (1990-11-01), None
patent: WO 91/00906 (1991-01-01), None
patent: WO 91/10741 (1991-07-01), None
patent: WO 92/03918 (1992-03-01), None
patent: WO 92/04372 (1992-03-01), None
patent: WO 92/17497 (1992-10-01), None
patent: WO 94/02602 (1994-02-01), None
patent: WO 94/25585 (1994-11-01), None
patent: WO 94/28931 (1994-12-01), None
patent: WO 95/23865 (1995-09-01), None
patent: WO 96/02576 (1996-02-01), None
patent: WO 96/22785 (1996-08-01), None
patent: WO 96/33735 (1996-10-01), None
patent: WO 97/01354 (1997-01-01), None
patent: WO 97/13852 (1997-04-01), None
patent: WO 97/39772 (1997-10-01), None
patent: WO 97/39775 (1997-10-01), None
patent: WO 97/49426 (1997-12-01), None
patent: WO 98/17312 (1998-04-01), None
patent: WO 98/24884 (1998-06-01), None
patent: WO 98/58671 (1998-12-01), None
patent: WO 00/50079 (2000-08-01), None
patent: WO 00/57902 (2000-10-01), None
patent: WO 01/32879 (2001-05-01), None
patent: WO 01/32879 (2001-05-01), None
patent: WO 01/49321 (2001-07-01), None
patent: WO 01/57056 (2001-08-01), None
patent: WO 02/24217 (2002-03-01), None
Attwood , Science 2000; 290:471-473.
Skolnick et al. Trends in Biotech. 2000; 18(1):34-39.
Metzler et al. Nature Structural Biol. 1997; 4:527-531.
Alt et al. Immunoglobulin genes in transgenic mice,TIG—Aug. 231-6 (1985).
Berman et al. Content and organization of the human Ig VHlocus: definition of three new VHfamilies and linkage to the Ig CHlocus,EMBO J.7:727-38 (1988).
Berton et al. Synthesis of germ-line γ1 immunoglobulin heavy-chain transcripts in resting B cells: Induction by interleukin 4 and inhibition by interferon γ,PNAS USA86:2829-2833 (1989).
Bollag et al. Homologous recombination in mammalian cells,Annu. Rev. Genet.23:199-225 (1989).
Brüggemann et al. Human antibody production in transgenic mice: expression from 100 kb of the human lgH locus,Eur. J. Immunol.21:1323-1326 (1991).
Brüggemann et al. A repertoire of monoclonal antibodies with human heavy chains from transgenic mice,PNAS USA86:6709-6713 (1989).
Bucchini et al. Rearrangement of a chicken immunoglobulin gene occurs in the lymphoid lineage of transgenic mice,Nature326:409-411 (1987).
Buttin, Exogenous Ig gene rearrangement in transgenic mice: a new strategy for human monoclonal antibody production?TIG—vol. 3, No. 8 (Aug. 1987).
Capecchi, The new mouse genetics: Altering the genome by gene targeting,TIG5:70-76 (1989).
Capecchi, Altering the genome by homologous recombination,Science244:1288-1292 (1989).
Chen et al. Characterization Of Two Immunoglobulin VHGenes That Are Homologous to Human Rheumatoid Factors.Arthritis Rheum.32:72-76 (1989).
Coffman et al. T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ,J. Immunol.136:949-954 (1986).
Coffman et al. A mouse T cell product that preferentially enhances IgA production,J. Immunol.139:3685-3690 (1987).
Doetschman et al. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells,Nature330:576-578 (1987).
Durdik et al. Isotype switching by a microinjected μ immunoglobulin heavy chain gene in transgenic mice,PNAS USA86:2346-2350 (1989).
Esser et al. Rapid induction of transcription of unrearranged Sγ1 switch regions in activated murine B cells by interleukin 4,EMBO J.8:483-488 (1989).
Ferrier et al. Separate elements control DJ and VDJ rearrangement in a transgenic recombination substrate,EMBO J.9:117-125 (1990).
Fishwild et al. High-Avidity human IgGκ monoclonal antibodies from a novel strain of minilocus transgenic mice.Nature Biotechnology14:845 (1986).
Forni, extensive splenic B cell activation in IgM-transgenic mice,Eur. J. Immunol.20:983-989 (1990).
Gerstein et al. Isotype switching of an immunoglobulin heavy chain transgene occurs by dna recombination between different chromosomes,Cell63:537-548 (1990).
Goodhardt et al. Rearrangement and expression of rabbit immunoglobulin κ light chain gene in transgenic mice,PNAS USA84:4229-4233 (1987).
Gordon, Transgenic mice in immunology,The Mount Sinai Journal of Medicine53:223-231 (1986).
Green et al., Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs,Nature Genetics7:13-21 (1994).
Hagman et al. Inhibition of immunoglobulin gene rearrangement by the expression of a λ2 transgene,J. Exp. Med.169:1911-1929 (1989).
Hofker et al. Complete physical map of the human immunoglobulin heavy chain constant region gene complex,PNAS USA86:5567-5571 (1989).
Humphries et al. A new human immunoglobulin VHfamily preferentially rearranged in immature B-cell tumours,Nature331:446-9 (1988).
Ichihara et al. Organization of human immunoglobulin heavy chain diversity gene loci,EMBO J.7:4141-50 (1988).
Iglesias et al. Expression of immunoglobulin delta chain causes allelic exclusion in transgenic mice,Nature330:482-484 (1987).
Jaenisch, Transgenic Animals,Science240:1468-74 (1988).
Jakobovits et al. Analysis
Baadsgaard Ole
Hudson Debra
Parren Paul
Petersen Jürgen
Teeling Jessica
Chan Christina
Genmab A/S
Kim Yunsoo
Lahive & Cockfield, LLP.
Medarex Inc.
LandOfFree
Human monoclonal antibodies against interleukin 8 (IL-8) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human monoclonal antibodies against interleukin 8 (IL-8), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal antibodies against interleukin 8 (IL-8) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3903089